Skip to content

CONEMPHAR

Active Private limited companyfounded 2002active for 24 yearsAvenue Foch 768, 7012 MonsKBO/BCE: BE 0478.091.521 subsidiary of

Lifetime

23 annual accounts with figures on one time axis
peak of €305,581 in 2022
€271,075▼ 4.3%
lowest -€159,455 in 2006
€9,547▲ 16.5%
peak of €347,199 in 2025
€347,199▲ 2.8%
€1.0m▲ 7.8%
peak of 4.5 FTE in 2020
3.4 FTE▼ 24.4%
Board1 name since 2008
1 director
Owners4 names in the annual accounts
  
Documentsfilings and deeds
26-06-202635 days before the deadline
2025abbreviated format
Staff from 4.5 FTE to 3.4 FTECash from €72,702 to €111,875

Key points

from the 2025 annual accounts

Equity

€347,199 ▲ 2.8%

CONEMPHAR has made a profit without a break since 2021.

Debts

€1.0m 74% of the balance sheet
Financial debts 28%Suppliers 10%Taxes and wages 6%Other 57%

€232,716 of the debts are secured on the company's own assets. In 2021 that was €225,860.

Filings

23 annual accounts since 2003
AprilJune31 JulyOctober20102020

Two of the last ten came late. The 2019 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,985 companies had the same profile as CONEMPHAR has now. Each dot stands for 10 companies, two years later.

96.5%
were still trading
2.3%
stopped another way
1.1%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,985 companies, not a prediction for CONEMPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • consolidatesannual accounts 2010

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0478091521
reappointed as director acts as permanent representative · Legal-form conversion: from public limited company to private limited company · Name change: CONEMPHAR · General meeting of 29-12-2023 · Gazette deed
New establishment in Colfontaine DRAGON Pharma, Rue Jean Jean 3
reappointed as director General meeting of 20-04-2017 · Gazette deed
All 42 events

Comparable companies

same main activity, similar in size and age
Company
CONEMPHAR Mons €1.4m €271,075 25.5% 3.4
Apothekers MARIABURG Brasschaat Brasschaat €1.3m €265,463 42.6% 3.1
PHARMACIE H. DOCK Faimes €1.3m €299,419 55.4% 3.7
MANAGEMENT AELBERS Dilsen-Stokkem €1.3m €303,305 92.9% 3.4
PHARMACIE ERGO Estinnes €1.3m €309,919 66.4% 2.7
PHARMACIE G. DENEF Binche €1.5m €347,854 26.7% 3.7
D5-PHARMA Ganshoren €1.5m €299,257 7.8% 3

These companies have the same main activity as CONEMPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.3m and €1.5m, founded between 1998 and 2004.

Official details

Source: KBO
Status
Active since 30-07-2002Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2024
Establishment units
2.114.087.4827012 Mons, since 13-09-2002
2.285.719.4807340 Colfontaine, since 01-01-2019
Financial year end
31 December
Peppol
Reachable since 08-12-2025
Company details

Annual accounts 2025

≈ €930,000estimated
€1.4m▲ 6.5%
Employeeson 31-12-2025
5=
Filing
Filed on 26-06-2026, 35 days before the end of the filing period
Financials

Insights on CONEMPHAR

CONEMPHAR files the abbreviated format. That format states no turnover. The gross margin rose from €151,498 in 2003 to €271,075 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CONEMPHAR

What is the company number of CONEMPHAR?
The company number of CONEMPHAR is 0478.091.521. The VAT number is the same number with BE in front: BE 0478.091.521.
Where is CONEMPHAR based?
The registered office is at Avenue Foch 768, 7012 Mons.Company details
What does CONEMPHAR do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of CONEMPHAR?
CONEMPHAR is a private limited company (BV).
When was CONEMPHAR founded?
CONEMPHAR was founded on 30-07-2002.
Is CONEMPHAR still active?
Yes, CONEMPHAR is an active enterprise in the KBO register.
How many employees does CONEMPHAR have?
CONEMPHAR had an average of 3.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does CONEMPHAR fall under?
In its 2024 annual accounts, CONEMPHAR states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of CONEMPHAR?
The turnover in financial year 2025 is about €930,000. This figure is estimated from the gross margin of €271,075 and 42 comparable companies (NACE 477). It probably lies between €740,000 and €1.3m.
Is CONEMPHAR profitable?
In financial year 2025, CONEMPHAR made a profit of €9,547.
Where can I find the annual accounts of CONEMPHAR?
CONEMPHAR filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CONEMPHAR due?
CONEMPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.